Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

New Delhi: The race for top AI talent is heating up again, and this time it has an Indian-origin founder at the centre. Aman Gottumukkala, known for building a revenue-generating AI startup with just ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

OpenClaw will live on as an open-source project. OpenClaw will live on as an open-source project. is the Verge’s weekend editor. He has over 18 years of experience, including 10 years as managing ...

At 5 a.m. California time, when it is still dark outside, a member of the state's Department of Public Health gets on a weekly call. The topic? Health emergencies all over the world. For years, the ...

Jan 23 (Reuters) - California said on Friday it will become the first U.S. state to join the World Health Organization's global outbreak response network following the Trump administration's decision ...

According to God of Prompt on Twitter, MIT researchers have introduced a new prompt engineering technique called 'Recursive Meta-Cognition' that enables ChatGPT to reason like a team of experts rather ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...